← Back to All Filings

Natera Officer Files Form 144 Notice for 29,423 Shares

Low SignificanceSeptember 2, 2026 at 5:05:39 PM EDT

Natera, Inc.

$NTRA144CIK: 0001604821

Subscribe to track NTRA

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

Natera Officer Files Form 144 Notice for 29,423 Shares

Company: Natera, Inc. (NTRA) Form: Form 144 | Filed: 2026-09-02 Significance: Low

Insider: Solomon Moshkevich Relationship: Officer

Proposed Transaction: • Security: Common Stock • Shares to Sell: 29,423 • Source: RSU Vesting (Acquired 09/01/2026) • Approx Sale Date: 09/02/2026

Key Insight: Officer Solomon Moshkevich filed notice to sell 29,423 shares of common stock received from routine RSU vesting. The transaction represents roughly 0.02% of outstanding shares.

Comprehensive Analysis

SEC Filing Analysis: Natera, Inc. (NTRA)

Executive Summary

  • Trading Significance: Low
  • Key Takeaway: Officer Solomon Moshkevich filed a Form 144 notice covering the proposed sale of 29,423 common shares acquired via RSU vesting.
  • Market Impact: Neutral, as the proposed transaction represents a negligible fraction of total shares outstanding.

Company & Insider Overview

FieldValue
CompanyNatera, Inc.
TickerNTRA
CIK0001604821
Insider NameSolomon Moshkevich
RelationshipOfficer

Filing & Transaction Details

FieldValue
Form TypeForm 144
Notice Date2026-09-02
Approximate Sale Date2026-09-02
Security TypeCommon Stock
Proposed Shares to Sell29,423
Acquisition SourceRestricted Stock Units (RSUs)
BrokerETrade Corporation

Financial Impact Assessment

Transaction Materiality

MetricValue
Shares Proposed for Sale29,423
Shares Outstanding143,220,000
% of Shares Outstanding0.02%
Company Market Cap~$47.18B
Materiality AssessmentLow

Impact Evaluation

  • Market Cap Context: Across Natera's ~$47.18B market capitalization, a 29,423 share transaction is routine and standard executive equity monetization following an RSU vest.
  • Dilution & Concentration: The RSU grant settlement and subsequent sale represent ~0.02% of outstanding shares, posing virtually no market absorption friction or dilution risk.

Market Impact Analysis

  • Stock Direction: Neutral
  • Reasoning: Regular post-vesting Form 144 filings are common for corporate officers and do not indicate fundamental business shifts.
  • Volume & Sentiment: Minimal to no observable volume or sentiment impact expected given the small transaction size relative to average daily liquidity.
Topics:#SECFiling#Form144#NTRA#InsiderSelling#Natera#StockMarket#BiotechStocks

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.